Caledonia Investments (LON:CLDN) Insider Acquires £149.76 in Stock

Caledonia Investments Plc (LON:CLDN) insider Robert Memmott acquired 39 shares of Caledonia Investments stock in a transaction that occurred on Monday, July 27th. The stock was acquired at an average price of GBX 384 per share, with a total value of £149.76.

Robert Memmott also recently made the following trade(s):

• On Friday, June 26th, Robert Memmott purchased 43 shares of Caledonia Investments stock. The stock was bought at an average cost of GBX 355 per share, with a total value of £152.65.
• On Wednesday, May 27th, Robert Memmott acquired 41 shares of Caledonia Investments stock. The shares were bought at an average price of GBX 364 per share, for a total transaction of £149.24.

Caledonia Investments Stock Performance

Shares of CLDN opened at GBX 385.50 on Friday. The stock has a market capitalization of £1.97 billion, a price-to-earnings ratio of 15.12 and a beta of 0.81. Caledonia Investments Plc has a 52-week low of GBX 312 and a 52-week high of GBX 395. The stock’s 50-day simple moving average is GBX 367.92 and its 200 day simple moving average is GBX 357.61.

Caledonia Investments (LON:CLDN) last announced its quarterly earnings results on Tuesday, May 19th. The company reported GBX 7.70 earnings per share for the quarter. Caledonia Investments had a return on equity of 4.51% and a net margin of 81.74%.The firm had revenue of GBX 6,470 million for the quarter.

About Caledonia Investments

Caledonia is a FTSE 250 self-managed investment trust company with a long track record of delivering consistent returns and progressive annual dividend payments to shareholders.

Our aim is to generate long-term compounding real returns that outperform inflation by 3%-6% over the medium to long term, and the FTSE All-Share index over 10 years.

We are a long-term investor and hold investments in both listed and private markets across three pools: Public Companies, Private Capital and Funds. Each has a strategic allocation of capital, investment strategy and target return.

We buy to hold, investing in high quality companies with strong market positions and fundamentals, alongside investments in private equity funds with track records of success.